According to INmune Bio's latest financial reports the company has โน2.75 Billion in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2023-12-31 | $โน3.17 B | -36.16% |
2022-12-31 | $โน4.97 B | -16.71% |
2021-12-31 | $โน5.97 B | 110.68% |
2020-12-31 | $โน2.83 B | 68.34% |
2019-12-31 | $โน1.68 B | 45.58% |
2018-12-31 | $โน1.15 B | 0.05% |
2017-12-31 | $โน1.15 B | -11500.85% |
2016-12-31 | $-โน10.14 Million |